Firm Advises Top 5 Global Pharmaceutical Company on Unfair Competition and Public Tender

  • Dispute Resolution
  • Life Sciences

Marchenko Danevych advised one of the Top 5 Global pharmaceutical companies (Global 500 company) on the dispute resolution strategy to challenge unfair competition practices of a competing undertaking controlled by Ukrainian and U.S. investors, including the results of an annual public tender apparently procured through bribes and influence peddling.

We advised the Client to consider a combination of domestic unfair competition actions, U.S. FCPA and domestic anticorruption actions, and claims for damages.

This site uses cookies. An explanation of their purpose can be found within Terms of Use